Table 1 Sensitivity of pancreatic tumour cells to CD95-mediated apoptosis.

From: Multiple and synergistic deregulations of apoptosis-controlling genes in pancreatic carcinoma cells

Cell line

CH11 viability (%)

TRAIL viability (%)

Capan1

32.8±0.8

13.7±1.4

Colo357

66.6±1.5

31.9±0.7

PancTuI

95.7±4.1

86.7±4.0

Panc89

86.7±2.4

64.4±2.7

Panc1

98.6±0.3

75.4±3.0

  1. Cells were treated for 24 h with agonistic anti-CD95 antibody CH11 or with recombinant TRAIL. The viability of the cells was determined by JAM-Assay. Data represent means ± SD of three independent experiments performed 6-fold each
Back to article page